*
*Scleroderma|89155008|422801000
*
*
is
a chronic systemic autoimmune disease|27624003|31099001|263680009|90734009|264578000|263680009|90734009|31099001|85828009
(primarily
of the skin -"derma"|119325001|39937001|181469002
)
characterized
by fibrosis|263756000
(
or
hardening -"sclero"|19730000
)
,
vascular alterations,|59820001
and
autoantibodies.|30621004

There
are
two major forms|420797005|255603008|246176004
:

*
*Limited systemic sclerosis/scleroderma|299276009|43846000|299276009|299276009|89155008|299276009|422801000|255469002
*
*
involves|248448006
cutaneous manifestations|119325001|250255003|119325001|251190009|39937001|250255003|39937001|251190009|181469002|250255003|181469002|251190009
that mainly
affect|4065008
the hands,|85562004
arms,|40983000
and
face.|89545001|302549007

It
was
previously called CREST syndrome|31848007
in reference
to the following complications|255260001|116223007
:
*
*C
*
*alcinosis,
*
*R|24028007
*
*aynaud's phenomenon,
*
*E
*
*sophageal dysfunction,|386585008
*
*S**clerodactyly,|288495006
and
*
*T
*
*elangiectasias.

Additionally,
pulmonary arterial hypertension|26174007
may
occur|272120004
in
up to one-third|421379005|70905002
of patients|116154003
and
is
the most serious complication|4757001|42745003|116223007|4757001|42745003|263718001
for this form|246176004
of scleroderma.|89155008|422801000

*
*Diffuse systemic sclerosis/scleroderma|444133002|444133002|89155008|444133002|422801000|19648000
*
*
is
rapidly|418694008
progressing|255314001
and
affects|4065008
a large area|255509001|42798000
of the skin|119325001|39937001|181469002
and
one|421379005
or
more internal organs,|242762006|260521003|410653004
frequently|70232002
the kidneys,|64033007|17373004
esophagus,|32849002|181245004
heart,|80891009|302509004
and
lungs.|39607008

This form|246176004
of scleroderma|89155008|422801000
can
be
quite disabling.

There
are
no treatments|276239002
for scleroderma|89155008|422801000
itself,
but
individual organ system complications|125676002|91689009|116223007|385435006|91689009|116223007
are
treated.[1][2]|28995006

Other forms|74964007|246176004
of scleroderma|89155008|422801000
include|55919000
systemic sine scleroderma|89155008
(
which
lacks|41277001
skin changes|119325001|243326001|119325001|263703002|39937001|243326001|39937001|263703002|181469002|243326001|181469002|263703002
but
has
systemic manifestations|31099001|250255003|31099001|251190009
)
and
two localized forms,|420797005|255471002|246176004
morphea|201048007|201049004
and
linear scleroderma,|22784002
which
affect|4065008
the skin|119325001|39937001|181469002
but
not
the internal organs.|260521003|410653004

The prognosis|20481000
is
generally good|20572008
for limited cutaneous scleroderma patients|299276009|119325001|116154003|299276009|39937001|116154003|299276009|181469002|116154003
who
escape
pulmonary complications,|39607008|116223007|264164005|116223007
but
is
worse|230993007|390772001|231877006
for those with the diffuse cutaneous disease,|20401003|19648000|95320005|421463005|19648000|95320005
particularly
in older age,|105436006|32864002
and
for males.|248153007

Death|419620001|268923008
occurs|272120004
most often|70232002
from pulmonary, heart,|39607008|80891009|39607008|302509004|264164005|80891009|264164005|302509004
and
kidney complications.|64033007|116223007|17373004|116223007|181414000|116223007

In diffuse cutaneous disease,|19648000|95320005
five-year survival|421820001|258707000|421820001|259039008
is
70%,
and
10-year survival|258707000|259039008
is
55%.[3]|264691008

The cause|134198009
is
unknown.|261665006

Scleroderma|89155008|422801000
runs|282476009
in families|35359004
but
the genes|67271001
have
not
been
identified.|7882003

It
affects|4065008
the small blood vessels|27915009
(arterioles|28225005
)
in all organs.|410653004

First,|255216001|232714002
the endothelial cells|45709008
of the arteriole die off,|28225005|419620001|28225005|399069006|28225005|419099009|337724002|419620001|337724002|399069006|337724002|419099009
along
with smooth muscle cells,|122447002|4421005
by a process|415178003
of apoptosis.|20663007

They
are
replaced|282089006|370124000
by collagen|61472002
and
other fibrous material.|74964007|263756000|260769002|74964007|255423002|260769002

Inflammatory cells,|256923004
particularly CD4+ helper T cells,|29594005
infiltrate|47351003
the arteriole,|28225005|337724002
and
cause|23981006|134198009
further damage.|46053002|37782003

Many
of the inflammatory
and
destructive protein signals|255303004|88878007
have
been
identified|7882003
and
they
are
potential targets|30207005
for drugs|410942007
that
could
interrupt|261017006
the process.[1]|415178003

Scleroderma|89155008|422801000
is
characterized
by the appearance|386548000|255412001
of circumscribed|355648006
or
diffuse, hard, smooth, ivory-colored areas|19648000|72505002|82280004|103366001|42798000
that
are
immobile,|102491009
and
which
give|419582001
the appearance|386548000|255412001
of hidebound skin,|119325001|39937001|181469002
a disease|64572001
occurring|272120004
in
both
localized|255471002
and
systemic forms|31099001|246176004
:
[4]|260308009

Typical scleroderma|89155008|422801000
is
classically
defined
as symmetrical skin thickening,|18772005|17417006
with about 90%|264705001|264703008
of cases also|398241000|413769002
presenting|246105001
with Raynaud's phenomenon,|266261006
nail-fold capillary changes,|416596008|26310004|20982000|416596008|26310004|255416003
and
antinuclear antibodies.|45530001

Patients|116154003
may
or
may
not
experience
systemic organ involvement.|91689009|248448006

Atypical scleroderma|112231000|112231000|89155008|112231000|422801000
may
show
any variation|40885006
of these changes|243326001|263703002
without skin changes|119325001|243326001|119325001|263703002|39937001|243326001|39937001|263703002|181469002|243326001|181469002|263703002
or
with finger|7569003|302541005
swelling|423666004|442672001
only.|50607009|420295001

Additional symptoms|260364009
of scleroderma typically|89155008|422801000
present|52101004|246105001
themselves
within two years|420797005|258707000
of Raynaud's phenomenon.[7]|266261006

Laboratory testing|269814003
can
show
antitopoisomerase antibodies,|68498002
like anti-scl70
(
causing|23981006
a diffuse systemic form|19648000|31099001|246176004
)
,
or
anticentromere antibodies|68498002
(
causing|23981006
a limited systemic form,|255469002|31099001|246176004
and
the CREST syndrome.|31848007

Other autoantibodies|74964007|30621004
can
be
seen
,
such as anti-U3
or
anti-RNA polymerase.|74521006

Severe complications|24484000|116223007
from scleroderma|89155008|422801000
include|55919000
:

There
is
no direct cure|255589003
for scleroderma.|89155008|422801000

Because
the exact cause|134198009
is
unknown|261665006
,
any treatment|276239002|416118004
is
patient-specific|116154003|69658003
and
aimed
at ameliorating symptoms
of the disease.|64572001

For example,
patients|116154003
who
experience
Raynaud's phenomenon|266261006
may
be
treated|28995006
with agents to|260872001
increase|260366006
blood flow|58190003
to the fingers,|7569003|259052003
including|55919000
nifedipine,|387490003
amlodipine,|386864001
diltiazem,|372793000
felodipine,|386863007
or
nicardipine.|372502001

Fibrosis|263756000
of the skin|119325001|39937001|181469002
has
been
treated|28995006
with varying degrees|246173007
of success|385669000
with agents|260872001
such as D-penicillamine,|387235007
colchicine,|387413002
PUVA,
relaxin,|35466004
and
cyclosporine.|387467008

Because
scleroderma|89155008|422801000
is
an autoimmune disease,|85828009
one|421379005
of the major pillars|255603008
of treatment|276239002|416118004
involves|248448006
the use|277889008|419385000
of immunosuppressive agents.|372823004

These drugs|410942007
include|55919000
methotrexate,|387381009
cyclophosphamide,|387420009
azathioprine,|372574004
and
mycophenolate.[9][10]

Individuals|125676002|385435006
with morphea|201048007|201049004
or
limited scleroderma|299276009
have
a relatively positive outlook.|258758003|225464009|10828004|225464009

They
will
usually
die|419620001|399069006|419099009
from natural causes|510009|134198009
or
another disease,|64572001
perhaps,
but
not
from the scleroderma.|89155008|422801000

Those with very widespread skin|20401003|260358002|85333001|119325001|20401003|260358002|85333001|39937001|20401003|260358002|85333001|181469002|421463005|260358002|85333001|119325001|421463005|260358002|85333001|39937001|421463005|260358002|85333001|181469002
and
organ involvement|410653004|248448006
(systemic|31099001
)
have
a negative prognosis.|260385009|20481000

More women|242762006|224526002
have
scleroderma,|89155008|422801000
but
the disease kills more men.|64572001|248007002|339947000

Following|255260001
diagnosis,|439401001
two-thirds|420797005|70905002
of patients|116154003
live|419749002
at least 11 years.|276139006|258707000|263796003|258707000

The higher|75540009|371879000
the patient's age|116154003|424144002
at diagnosis,|439401001
the more likely|242762006|2931005
he
or
she
is
to
die|419620001|399069006|419099009
from the disease.|64572001

People|125676002
with scleroderma|89155008|422801000
have
very different life expectancies.|260358002|263735002|224130005|410517006

Some ?
for example,
those
with limited|255469002
or
mild diffuse disease ?|255604002|19648000|64572001
can
expect
to
live|419749002
20
to 50 years|258707000
after diagnosis.|439401001

Others|74964007
with severe, rapidly progressive disease ?|24484000|418694008|255314001|64572001
a group|261586004|160481000|389109008
which
makes
up less|276139006|263796003
than 10%
of the total number|258755000|410680006|258755000|410681005|255619001|410680006|255619001|410681005
of patients|116154003
with diffuse scleroderma ?|89155008|444133002
might
have
a 50% chance
of a five-year survival.[11]|421820001|258707000|421820001|259039008

This disease|64572001
is
found|404684003
among all
races|415229000
worldwide,
but
women|224526002
are
four|421534005
times more likely to|242762006|2931005
develop
scleroderma|89155008|422801000
than men.|339947000

In the United States,|223688001
approximately one person|26175008|421379005|125676002
in 1,000|260305007
is
affected.|247591002|248448006

Children rarely|410601007|103356009|160499008|103356009
suffer
the systemic type,|31099001|261664005
but
localized scleroderma|201048007
is
common.|72906007

Most adults|133936004
are
diagnosed|439401001
after their 30th birthday
and
before age 50.|424144002

The disease|64572001
has
high rates|75540009|371879000
among the native American Choctaw tribe|413490006|297784002
and
African-American females.[7]|15086000|248152002

Cases|398241000|413769002
of skin disease|95320005
similar
to scleroderma|89155008|422801000
may
be
found|404684003
in the writings
of Hippocrates
as far|46053002
back
as 460?370 B.C.

Oribasius
(325?403 A.D.
)
and
Paulus Aegineta
(625?690 A.D.
)
also
wrote|12261009
on the subject.

It
is
difficult to|52925006
know|36692007
if
these
were
truly examples
of scleroderma|89155008|422801000
because
the descriptions
were
inexact.

The first definite description|255216001|255545003|232714002|255545003
of the disease,|64572001
by Carlo Curzio|262364003
in a monograph
published
in Naples
in 1753,
produced
considerable interest|225469004
in French|19434008
and
English medical circles.|297487008|74188005|354652004|25804004|74188005|354652004

The account
concerns
a young woman|84422007|224526002
of 17 named Patrizia Galiera,|27468005
who
was
admitted|32485007
to the hospital|285201006
and
assigned
to Dr.|309343006

Curzio.

Her symptoms
as
described
by the doctor|309343006
involved|248448006
hardness|72505002
of the skin|119325001|39937001|181469002
(differing
in degree|258395000|246173007
from place to|257557008|421066005
place|257557008|421066005
)
,
tightness|255365009
around the mouth,|74262004|123851003|21082005|181220002
and
hardness|72505002
around the neck.|45048000|302550007

He
noted loss
of warmth|71384000
in the skin,|119325001|39937001|181469002
but
no other problem|74964007|55607006
in pulse,|410194008|78564009|8499008
respiration,|258162000
or
digestion.|106079008

Much
of the report|229059009|223458004
contains|42504009
details
of the treatment,|276239002|416118004
which
included|55919000
warm milk|3718001|119321005|70813002
and
vapor baths,
bleeding|131148009
from the foot,|56459004|259051005|302545001
and
small doses|255507004|277406006
of quicksilver|45262002
(mercury|45262002
).

After 11 months,|258706009
the skin|119325001|39937001|181469002
became
soft|37378003
and
flexible,|261012000
and
all natural functions|510009|246464006
were
restored.

Curzio's observations,|103705002
published
in French|19434008
in 1755,
aroused|27625002
considerable interest.|225469004

The early dermatological texts|264499004
of R.|24028007

William
in London
(1808
)
and
his student,|65853000
J.

L.|258995007|420559008

Alibert,
in Paris|7074004
(1818
)
referred|439980006
to Curzio's observation.[12]|103705002

M
:
INT,
SF,
LCT

anat/phys/devp

noco
(i/b/d/q/u/r/p/m/k/
v/
f/cong/tumr|372639009
(n/e/d,|258310009
sysi/epon

proc,
drug|410942007
(D2/3/4/5/8/11

M
:
MUS,|223541006|447482001
DF+DRCT

anat (h/n,|89177007|258322007|286551008
u,
t/d,
a/p,
l/phys/devp/hist|258995007|420559008

noco
(m,|258311008
s,|288495006
c/cong
(d/tumr,|876000
sysi/epon,
injr

proc,
drug|410942007
(M1A/3|261927002

